Global Mycology Immunoassays Testing Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Mycology Immunoassays Testing Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Mycology immunoassays testing is a diagnostic method used to detect fungal infections by measuring specific immune responses to fungal antigens in patient samples.
Global Mycology Immunoassays Testing market is projected to reach US$ 2605.3 million in 2029, increasing from US$ 1795.7 million in 2022, with the CAGR of 5.4% during the period of 2024 to 2029. Demand from Hospitals and Blood Banks are the major drivers for the industry.
The market for mycology immunoassays testing is driven by the need for accurate and timely diagnosis of fungal infections, which can have serious consequences if left untreated. The market's growth is also influenced by the increasing prevalence of fungal infections, particularly in immunocompromised individuals, and advancements in immunoassay technology, leading to improved sensitivity and specificity of fungal diagnostic tests.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Mycology Immunoassays Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report

Roche
Abbott
Siemens
Beckman Coulter
Ortho-Clinical Diagnostics
bioMérieux
ELITechGroup
MiraVista Diagnostics
Autobio Diagnostics CO.,Ltd.
CapitalBio Corporation
Segment by Type
ELISA
Rapid Tests
ELISPOT
Polymerase Chain Reaction (PCR)
Hospitals
Blood Banks
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Mycology Immunoassays Testing market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Mycology Immunoassays Testing introduction, etc. Mycology Immunoassays Testing Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Mycology Immunoassays Testing market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Global Mycology Immunoassays Testing market is projected to reach US$ 2605.3 million in 2029, increasing from US$ 1795.7 million in 2022, with the CAGR of 5.4% during the period of 2024 to 2029. Demand from Hospitals and Blood Banks are the major drivers for the industry.
The market for mycology immunoassays testing is driven by the need for accurate and timely diagnosis of fungal infections, which can have serious consequences if left untreated. The market's growth is also influenced by the increasing prevalence of fungal infections, particularly in immunocompromised individuals, and advancements in immunoassay technology, leading to improved sensitivity and specificity of fungal diagnostic tests.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Mycology Immunoassays Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report

By Company
Roche
Abbott
Siemens
Beckman Coulter
Ortho-Clinical Diagnostics
bioMérieux
ELITechGroup
MiraVista Diagnostics
Autobio Diagnostics CO.,Ltd.
CapitalBio Corporation
Segment by Type
ELISA
Rapid Tests
ELISPOT
Polymerase Chain Reaction (PCR)
Segment by Application
Hospitals
Blood Banks
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Mycology Immunoassays Testing market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Mycology Immunoassays Testing introduction, etc. Mycology Immunoassays Testing Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Mycology Immunoassays Testing market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
